

06 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/06/3213533/0/en/Sparrow-Pharmaceuticals-Announces-First-Patient-Enrolled-in-Phase-2b-Clinical-Trial-Evaluating-Clofutriben-for-Difficult-to-Control-Type-2-Diabetes.html

24 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/24/3155451/0/en/Sparrow-Pharmaceuticals-Announces-95-Million-Series-B-Financing-to-Advance-Targeted-Therapy-for-Type-2-Diabetes.html

11 Dec 2024
// BUSINESSWIRE